These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 62050)

  • 41. Proceedings: Kinetics of distribution and elimination of a basic lipophilic drug metabolite in the rat.
    Breyer U; Vïllumsen K
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R13. PubMed ID: 4152358
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparative pharmacokinetics of coumarin anticoagulants. XLVI: Effect of treatment of phenobarbital on pharmacokinetics of (S)-(-)-warfarin in rats.
    Yacobi A; Slattery JT; Levy G
    J Pharm Sci; 1980 Jun; 69(6):634-6. PubMed ID: 7205571
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of induction and inhibition of drug metabolism on pharmacokinetics and anticoagulant activity of the enantiomers of phenprocoumon in rats.
    Schmidt W; Trenk D; Jähnchen E
    Pharmacology; 1980; 21(5):313-22. PubMed ID: 7433511
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative pharmacokinetics of coumarin anticoagulants XV: relationship between pharmacokinetics of dicumarol and warfarin in rats.
    Yacobi A; Lai CM; Levy G
    J Pharm Sci; 1975 Dec; 64(12):1995-98. PubMed ID: 54415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative pharmacokinetics of coumarin anticoagulants. 3. Factors affecting the distribution and elimination of bishydroxycoumarin (BHC) in isolated liver perfusion studies.
    Nagashima R; Levy G; Sarcione EJ
    J Pharm Sci; 1968 Nov; 57(11):1881-8. PubMed ID: 4177835
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative pharmacokinetics of coumarin anticoagulants XXXIII: frequency distribution of dicumarol total clearance in rats.
    Lai CM; Levy G
    J Pharm Sci; 1978 Mar; 67(3):337-40. PubMed ID: 76673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative pharmacokinetics of coumarin anticoagulants XXXVII: Simultaneous in vivo displacement of dicumarol from serum protein and tissue binding sites by tolbutamide in rats.
    Lai CM; Levy G
    J Pharm Sci; 1978 Oct; 67(10):1492-3. PubMed ID: 81299
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats.
    Yacobi A; Levy G
    J Pharm Sci; 1975 Oct; 64(10):1660-4. PubMed ID: 1195101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-protein binding: a method for studying the interactions of drugs with bishydroxycoumarin (dicoumarol) in dogs.
    Welch RM
    Ann N Y Acad Sci; 1973 Nov; 226():259-66. PubMed ID: 4129139
    [No Abstract]   [Full Text] [Related]  

  • 50. Influence of liver enzyme induction caused by phenobarbital on the biotransformation of hetacillin in male rats.
    Galanpoulou P; Karageorgiou C; Kouvaris M; Varonos D
    J Antimicrob Chemother; 1980 Jan; 6(1):157-9. PubMed ID: 7358613
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of perfusion rate and distribution factors on drug elimination kinetics in a perfused organ system.
    Nagashima R; Levy G
    J Pharm Sci; 1968 Nov; 57(11):1991-3. PubMed ID: 4177837
    [No Abstract]   [Full Text] [Related]  

  • 52. Factors affecting the excretion of 14C-dicumarol in the bile of rats.
    Kary CD; Wosilait WD
    Gen Pharmacol; 1976 Sep; 7(4):277-82. PubMed ID: 61903
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An autoradiographic study of the distribution and excretion of 14C-dicoumarol in the rat.
    Maines MD; Wosilait WD
    Comp Gen Pharmacol; 1971 Jun; 2(6):184-8. PubMed ID: 4125708
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of salicylate on the fate of bishydroxycoumarin in the rat.
    Thomas BH; Coldwell BB; Buttar HS; Zeitz W
    Can J Physiol Pharmacol; 1973 Mar; 51(3):205-12. PubMed ID: 4122297
    [No Abstract]   [Full Text] [Related]  

  • 55. An experimental model in dogs for studying interactions of drugs with bishydroxycoumarin.
    Welch RM; Harrison YE; Conney AH; Burns JJ
    Clin Pharmacol Ther; 1969; 10(6):817-25. PubMed ID: 4186901
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparative pharmacokinetics of coumarin anticoagulants. II. Pharmacokinetics of bishydroxycoumarin elimination in the rat, guinea pig, dog, and rhesus monkey.
    Nagashima R; Levy G; Back N
    J Pharm Sci; 1968 Jan; 57(1):68-71. PubMed ID: 4172324
    [No Abstract]   [Full Text] [Related]  

  • 57. The effect of chloral hydrate on bishydroxycoumarin metabolism; a fatal outcome.
    Cucinell SA; Odessky L; Weiss M; Dayton PG
    JAMA; 1966 Aug; 197(5):366-8. PubMed ID: 4161665
    [No Abstract]   [Full Text] [Related]  

  • 58. Proceedings: Pharmacokinetic analysis of the dicumarol-tolbutamide interaction in man.
    Jähnchen E; Gilfrich HJ; Groth U; Meinertz T
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R88. PubMed ID: 49859
    [No Abstract]   [Full Text] [Related]  

  • 59. Increased bishydroxycoumarin requirements in patients receiving phenobarbital.
    Goss JE; Dickhaus DW
    N Engl J Med; 1965 Nov; 273(20):1094-5. PubMed ID: 4158082
    [No Abstract]   [Full Text] [Related]  

  • 60. Relation between drug elimination kinetics in intact animals and isolated perfused liver systems: phenylbutazone.
    von Bahr C; Sjöqvist F; Levy G
    J Pharm Pharmacol; 1970 Nov; 22(11):867-8. PubMed ID: 4100288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.